Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
14.82
-0.47 (-3.07%)
Oct 22, 2025, 4:00 PM EDT - Market closed

Amylyx Pharmaceuticals Revenue

Amylyx Pharmaceuticals had revenue of $-249.00K in the twelve months ending June 30, 2025, down -100.08% year-over-year. In the year 2024, Amylyx Pharmaceuticals had annual revenue of $87.37M, down -77.06%.

Revenue (ttm)
$-249.00K
Revenue Growth
-100.08%
P/S Ratio
-6,348.64
Revenue / Employee
n/a
Employees
123
Market Cap
1.58B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202487.37M-293.42M-77.06%
Dec 31, 2023380.79M358.56M1,612.94%
Dec 31, 202222.23M21.95M7,700.00%
Dec 31, 2021285.00K-365.00K-56.15%
Dec 31, 2020650.00K-776.00K-54.42%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings